| SHPMY Stock | | | USD 8.20 0.32 4.06% |
CFO
Mr. Shen Bo was serving as Chief Financial Officer, Vice President and Executive Director in Shanghai Pharmaceuticals Holding Co., Ltd. since October 2016. He also serves as NonExecutive Director in Tianda Pharmaceuticals Limited and Shanghai FudanZhangjiang BioPharmaceutical Co., Ltd. He was Deputy ManagerFinance in Shanghai Jinling Co., Ltd, Chief Financial Officer in Shanghai Industrial Pharmaceutical Investment Co Ltd. and another company, as well as General ManagerFinance in Shanghai Pharmaceutical Co., Ltd. He holds a Master degree in Accounting from The Chinese University of Hong Kong, and a Bachelor degree in Accounting from a university which is now called Tongji University, China. He is a Certified Public Accountant. since 2016.
| Age | 50 |
| Tenure | 8 years |
| Phone | 86 21 6373 0908 |
| Web | https://www.sphchina.com |
Shanghai Pharmaceuticals Management Efficiency
The company has return on total asset
(ROA) of
0.0281 % which means that it generated a profit of $0.0281 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
0.1024 %, meaning that it generated $0.1024 on every $100 dollars invested by stockholders. Shanghai Pharmaceuticals' management efficiency ratios could be used to measure how well Shanghai Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.
Shanghai Pharmaceuticals Holding has accumulated 7.16
B in total debt with debt to equity ratio
(D/E) of 0.6, which is about average as compared to similar companies. Shanghai Pharmaceuticals has a current ratio of 1.37, which is within standard range for the sector. Debt can assist Shanghai Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Shanghai Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Shanghai Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Shanghai to invest in growth at high rates of return. When we think about Shanghai Pharmaceuticals' use of debt, we should always consider it together with cash and equity.
Similar Executives
Shanghai Pharmaceuticals Holding Co., Ltd., an investment holding company, researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in the Peoples Republic of China. Shanghai Pharmaceuticals Holding Co., Ltd. is a subsidiary of Shanghai Pharmaceutical Co., Ltd. Shanghai Pharmaceuticals operates under Medical Distribution classification in the United States and is traded on OTC Exchange. It employs 46577 people. Shanghai Pharmaceuticals Holding [SHPMY] is a
Pink Sheet which is traded between brokers as part of OTC trading.
Management Performance
Shanghai Pharmaceuticals Leadership Team
Elected by the shareholders, the Shanghai Pharmaceuticals' board of directors comprises two types of representatives: Shanghai Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Shanghai. The board's role is to monitor Shanghai Pharmaceuticals' management team and ensure that shareholders' interests are well served. Shanghai Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Shanghai Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
Shanghai Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Shanghai Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Shanghai Pink Sheet Analysis
When running Shanghai Pharmaceuticals' price analysis, check to
measure Shanghai Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shanghai Pharmaceuticals is operating at the current time. Most of Shanghai Pharmaceuticals' value examination focuses on studying past and present price action to
predict the probability of Shanghai Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shanghai Pharmaceuticals' price. Additionally, you may evaluate how the addition of Shanghai Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.